» Articles » PMID: 15177038

The Kinase Activity of DNA-PK is Required to Protect Mammalian Telomeres

Overview
Publisher Elsevier
Date 2004 Jun 5
PMID 15177038
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The kinase activity of DNA-dependent protein kinase (DNA-PK) is required for efficient repair of DNA double-strand breaks (DSB) by non-homologous end joining (NHEJ). DNA-PK also participates in protection of mammalian telomeres, the natural ends of chromosomes. Here we investigate whether the kinase activity of DNA-PK is similarly required for effective telomere protection. DNA-PK proficient mouse cells were exposed to a highly specific inhibitor of DNA-PK phosphorylation designated IC86621. Chromosomal end-to-end fusions were induced in a concentration-dependent manner, demonstrating that the telomere end-protection role of DNA-PK requires its kinase activity. These fusions were uniformly chromatid-type, consistent with a role for DNA-PK in capping telomeres after DNA replication. Additionally, fusions involved exclusively telomeres produced via leading-strand DNA synthesis. Unexpectedly, the rate of telomeric fusions induced by IC86621 exceeded that which occurs spontaneously in DNA-dependent protein kinase catalytic subunit (DNA-PKcs) mutant cells by up to 110-fold. One explanation, that IC86621 might inhibit other, as yet unknown proteins, was ruled out when the drug failed to induce fusions in DNA-PKcs knock-out mouse cells. IC86621 did not induce fusions in Ku70 knock-out cells suggesting the drug requires the holoenzyme to be effective. ATM also is required for effective chromosome end protection. IC86621 increased fusions in ATM knock-out cells suggesting DNA-PK and ATM act in different telomere pathways. These results indicate that the kinase activity of DNA-PK is crucial to reestablishing a protective terminal structure, specifically on telomeres replicated by leading-strand DNA synthesis.

Citing Articles

DNA-PK controls Apollo's access to leading-end telomeres.

Sonmez C, Toia B, Eickhoff P, Matei A, El Beyrouthy M, Wallner B Nucleic Acids Res. 2024; 52(8):4313-4327.

PMID: 38407308 PMC: 11077071. DOI: 10.1093/nar/gkae105.


DNA-PKcs: A Targetable Protumorigenic Protein Kinase.

Dylgjeri E, Knudsen K Cancer Res. 2021; 82(4):523-533.

PMID: 34893509 PMC: 9306356. DOI: 10.1158/0008-5472.CAN-21-1756.


DNA-dependent protein kinase in telomere maintenance and protection.

Sui J, Zhang S, Chen B Cell Mol Biol Lett. 2020; 25:2.

PMID: 31988640 PMC: 6969447. DOI: 10.1186/s11658-020-0199-0.


DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis.

Habiel D, Hohmann M, Espindola M, Coelho A, Jones I, Jones H BMC Pulm Med. 2019; 19(1):165.

PMID: 31464599 PMC: 6716822. DOI: 10.1186/s12890-019-0922-7.


DNA-PK as an Emerging Therapeutic Target in Cancer.

Mohiuddin I, Kang M Front Oncol. 2019; 9:635.

PMID: 31380275 PMC: 6650781. DOI: 10.3389/fonc.2019.00635.